List of Tables
Table 1. Global Amifostine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Amifostine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Amifostine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Amifostine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Amifostine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Amifostine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Amifostine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Amifostine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Amifostine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Amifostine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amifostine, Product Type & Application
Table 12. Global Key Manufacturers of Amifostine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amifostine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amifostine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amifostine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Amifostine Sales by Region (2019-2024) & (K Units)
Table 18. Global Amifostine Sales Market Share by Region (2019-2024)
Table 19. Global Amifostine Sales by Region (2025-2030) & (K Units)
Table 20. Global Amifostine Sales Market Share by Region (2025-2030)
Table 21. Global Amifostine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Amifostine Revenue Market Share by Region (2019-2024)
Table 23. Global Amifostine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Amifostine Revenue Market Share by Region (2025-2030)
Table 25. North America Amifostine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Amifostine Sales by Country (2019-2024) & (K Units)
Table 27. North America Amifostine Sales by Country (2025-2030) & (K Units)
Table 28. North America Amifostine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Amifostine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Amifostine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Amifostine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Amifostine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Amifostine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Amifostine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Amifostine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Amifostine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Amifostine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Amifostine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Amifostine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Amifostine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Amifostine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Amifostine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Amifostine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Amifostine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Amifostine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Amifostine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Amifostine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Amifostine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Amifostine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Amifostine Sales (K Units) by Type (2019-2024)
Table 51. Global Amifostine Sales (K Units) by Type (2025-2030)
Table 52. Global Amifostine Sales Market Share by Type (2019-2024)
Table 53. Global Amifostine Sales Market Share by Type (2025-2030)
Table 54. Global Amifostine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Amifostine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Amifostine Revenue Market Share by Type (2019-2024)
Table 57. Global Amifostine Revenue Market Share by Type (2025-2030)
Table 58. Global Amifostine Price (USD/Unit) by Type (2019-2024)
Table 59. Global Amifostine Price (USD/Unit) by Type (2025-2030)
Table 60. Global Amifostine Sales (K Units) by Application (2019-2024)
Table 61. Global Amifostine Sales (K Units) by Application (2025-2030)
Table 62. Global Amifostine Sales Market Share by Application (2019-2024)
Table 63. Global Amifostine Sales Market Share by Application (2025-2030)
Table 64. Global Amifostine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Amifostine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Amifostine Revenue Market Share by Application (2019-2024)
Table 67. Global Amifostine Revenue Market Share by Application (2025-2030)
Table 68. Global Amifostine Price (USD/Unit) by Application (2019-2024)
Table 69. Global Amifostine Price (USD/Unit) by Application (2025-2030)
Table 70. Clinigen Corporation Information
Table 71. Clinigen Description and Business Overview
Table 72. Clinigen Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Clinigen Amifostine Product
Table 74. Clinigen Recent Developments/Updates
Table 75. Sun Pharmaceutical Corporation Information
Table 76. Sun Pharmaceutical Description and Business Overview
Table 77. Sun Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Sun Pharmaceutical Amifostine Product
Table 79. Sun Pharmaceutical Recent Developments/Updates
Table 80. Taj Pharmaceuticals Corporation Information
Table 81. Taj Pharmaceuticals Description and Business Overview
Table 82. Taj Pharmaceuticals Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Taj Pharmaceuticals Amifostine Product
Table 84. Taj Pharmaceuticals Recent Developments/Updates
Table 85. Merro Pharmaceutical Corporation Information
Table 86. Merro Pharmaceutical Description and Business Overview
Table 87. Merro Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Merro Pharmaceutical Amifostine Product
Table 89. Merro Pharmaceutical Recent Developments/Updates
Table 90. Luye Pharma Corporation Information
Table 91. Luye Pharma Description and Business Overview
Table 92. Luye Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Luye Pharma Amifostine Product
Table 94. Luye Pharma Recent Developments/Updates
Table 95. Mingren Pharma Corporation Information
Table 96. Mingren Pharma Description and Business Overview
Table 97. Mingren Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Mingren Pharma Amifostine Product
Table 99. Mingren Pharma Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Amifostine Distributors List
Table 103. Amifostine Customers List
Table 104. Amifostine Market Trends
Table 105. Amifostine Market Drivers
Table 106. Amifostine Market Challenges
Table 107. Amifostine Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Amifostine
Figure 2. Global Amifostine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Amifostine Market Share by Type in 2023 & 2030
Figure 4. 400mg/Dose Product Picture
Figure 5. 500mg/Dose Product Picture
Figure 6. Global Amifostine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Amifostine Market Share by Application in 2023 & 2030
Figure 8. Head and Neck Cancer Adjuvant Therapy
Figure 9. Others
Figure 10. Global Amifostine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Amifostine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Amifostine Sales (2019-2030) & (K Units)
Figure 13. Global Amifostine Average Price (USD/Unit) & (2019-2030)
Figure 14. Amifostine Report Years Considered
Figure 15. Amifostine Sales Share by Manufacturers in 2023
Figure 16. Global Amifostine Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Amifostine Players: Market Share by Revenue in 2023
Figure 18. Amifostine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Amifostine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Amifostine Sales Market Share by Country (2019-2030)
Figure 21. North America Amifostine Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Amifostine Sales Market Share by Country (2019-2030)
Figure 25. Europe Amifostine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Amifostine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Amifostine Revenue Market Share by Region (2019-2030)
Figure 33. China Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Amifostine Sales Market Share by Country (2019-2030)
Figure 44. Latin America Amifostine Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Amifostine Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Amifostine Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Amifostine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Amifostine by Type (2019-2030)
Figure 54. Global Revenue Market Share of Amifostine by Type (2019-2030)
Figure 55. Global Amifostine Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Amifostine by Application (2019-2030)
Figure 57. Global Revenue Market Share of Amifostine by Application (2019-2030)
Figure 58. Global Amifostine Price (USD/Unit) by Application (2019-2030)
Figure 59. Amifostine Value Chain
Figure 60. Amifostine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed